Pharmaceutical News

RSS
Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Nanoplastics impair antibiotic effectiveness and promote resistance

Nanoplastics impair antibiotic effectiveness and promote resistance

Radioprotective effects of Licochalcone B against radiation-induced cell damage

Radioprotective effects of Licochalcone B against radiation-induced cell damage

Unraveling the mechanism of Shufeng Jiedu Capsules in influenza treatment

Unraveling the mechanism of Shufeng Jiedu Capsules in influenza treatment

Expanded access to weight-loss drugs could save thousands of lives

Expanded access to weight-loss drugs could save thousands of lives

Bioactive peptides from Chlorella vulgaris for therapeutic applications

Bioactive peptides from Chlorella vulgaris for therapeutic applications

Tenofovir amibufenamide does not alter lipid levels in patients with chronic hepatitis B

Tenofovir amibufenamide does not alter lipid levels in patients with chronic hepatitis B

New trial shows felzartamab reduces proteinuria in IgA nephropathy patients

New trial shows felzartamab reduces proteinuria in IgA nephropathy patients

New analysis confirms canagliflozin's cardiovascular and kidney benefits in older adults

New analysis confirms canagliflozin's cardiovascular and kidney benefits in older adults

Study: GLP-1RA not associated with acute kidney injury risk during anti-cancer treatments

Study: GLP-1RA not associated with acute kidney injury risk during anti-cancer treatments

Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity

Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity

Ipsen's elafibranor recommended for use in patients with rare liver disease

Ipsen's elafibranor recommended for use in patients with rare liver disease

MHRA greenlights donanemab for early stage Alzheimer’s disease

MHRA greenlights donanemab for early stage Alzheimer’s disease

Surge in GLP-1 drug use for obesity coincides with drop in bariatric surgery

Surge in GLP-1 drug use for obesity coincides with drop in bariatric surgery

Taurine supplementation linked to reduced atherosclerotic plaque development

Taurine supplementation linked to reduced atherosclerotic plaque development

Endophyte fermentation boosts isofraxidin levels in Sarcandra glabra

Endophyte fermentation boosts isofraxidin levels in Sarcandra glabra

Study reveals misuse of scientific evidence by opioid makers

Study reveals misuse of scientific evidence by opioid makers

Semaglutide may reduce Alzheimer's risk in diabetics

Semaglutide may reduce Alzheimer's risk in diabetics

Antibiotic for liver disease linked to emergence of antimicrobial resistant superbug

Antibiotic for liver disease linked to emergence of antimicrobial resistant superbug

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.